MOLLY BOYLE-ENGEDAL: Open Payments
NPI 1730676537 · EAU CLAIRE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 46 payments from 11 companies in 2025. Trend: 2023 $384 · 2024 $402 · 2025 $577
Food & beverage: $568Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $193 |
| Janssen Biotech, Inc. | 10 | $134 |
| Novo Nordisk Inc | 2 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| GENZYME CORPORATION | 1 | $39 |
| Lilly USA, LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: TREMFYA, CREON, DUPIXENT, Wegovy, XIFAXAN, LINZESS, OMVOH, RINVOQ.
Industry payments across WI — which companies pay providers there.
